Evidence map›Paper›PMID 38417545›Full record

ReviewNeuropharmacology2024

Opioid modulation of prefrontal cortex cells and circuits.

Rebecca H Cole, Khaled Moussawi, Max E Joffe

Open access · greenAbstract readReview
In one paragraph

Review in Neuropharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Impairment of the GABAergic system in the prefrontal cortex of male heroin addicts.European archives of psychiatry and clinical neuroscience · 2026
    Article
  5. Review
  6. Sex-specific role of the 5-HTNature communications · 2025
    Article
  7. Opioid Receptors Modulate Inhibition within the Prefrontal Cortex through Dissociable Cellular and Molecular Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  8. Mimicking opioid analgesia in cortical pain circuits.bioRxiv : the preprint server for biology · 2025
    Article
  9. Review
  10. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rebecca H ColeDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15219, USA; Translational Neuroscience Program, University of Pittsburgh, Pittsburgh, PA, USA; Center for Neuroscience University of Pittsburgh, Pittsburgh, PA, USA.
Khaled MoussawiDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15219, USA; Translational Neuroscience Program, University of Pittsburgh, Pittsburgh, PA, USA; Center for Neuroscience University of Pittsburgh, Pittsburgh, PA, USA.
Max E JoffeDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15219, USA; Translational Neuroscience Program, University of Pittsburgh, Pittsburgh, PA, USA; Center for Neuroscience University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: joffeme@upmc.edu.
University of Pittsburgh · US

Funding

TMS effects on circuit plasticity and drug seeking in mice - Diversity SupplementR00DA048085 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MOUSSAWI, KHALED · 2021 to 2023
$930k
Sex differences in fast-spiking interneurons promote AUD-related PFC dysfunction: remediation by modulating mGlu1 and mGlu5 - Supplement RevR00AA027806 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOFFE, MAX E · 2021 to 2023
$826k
NIAAA NIH HHS R00 AA027806NIDA NIH HHS R00 DA048085
6 · The paper itself

Abstract

Several neurochemical systems converge in the prefrontal cortex (PFC) to regulate cognitive and motivated behaviors. A rich network of endogenous opioid peptides and receptors spans multiple PFC cell types and circuits, and this extensive opioid system has emerged as a key substrate underlying reward, motivation, affective behaviors, and adaptations to stress. Here, we review the current evidence for dysregulated cortical opioid signaling in the pathogenesis of psychiatric disorders. We begin by providing an introduction to the basic anatomy and function of the cortical opioid system, followed by a discussion of endogenous and exogenous opioid modulation of PFC function at the behavioral, cellular, and synaptic level. Finally, we highlight the therapeutic potential of endogenous opioid targets in the treatment of psychiatric disorders, synthesizing clinical reports of altered opioid peptide and receptor expression and activity in human patients and summarizing new developments in opioid-based medications. This article is part of the Special Issue on "PFC circuit function in psychiatric disease and relevant models".

Indexed as

Analgesics, OpioidMental DisordersHumansMotivationPrefrontal CortexSignal TransductionAnalgesics, OpioidAddictionElectrophysiologyG protein-coupled receptor (GPCR)InterneuronsPlasticityRodent models

Identifiers

PMID38417545
PMCPMC10939756
OpenAlexW4392196038

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.